Clinical Trials Directory

Trials / Completed

CompletedNCT01516853

Non-invasive Quantification of Liver Iron With MRI

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to validate magnetic resonance imaging as a biomarker of hepatic iron concentration (HIC). Excessive accumulation of iron in the body is highly toxic, specifically in the liver. Accurate, non-invasive assessment of HIC is needed for diagnosis, quantitative staging and treatment monitoring or hepatic iron overload.

Detailed description

Excessive accumulation of iron in the body can result from abnormal intestinal absorption in hereditary hemochromatosis or repeated intravenous blood transfusions (ie: transfusional hemosiderosis). Excess body iron is highly toxic, and requires treatment aimed at reducing body iron stores. Measurement of body iron stores is critical for detection of iron overload, staging its severity and monitoring of iron-reducing therapies that are often extremely expensive (\>$40,000/year) and carry their own toxicities. MRI has been shown to be very sensitive to the presence of iron. The investigators have developed an MRI-based method for rapid iron quantification (for instance, whole liver in a single breath-hold). The purpose of this work is to validate this new method using the FDA-approved Ferriscan technique (Resonance Health, Claremont, Australia) as a reference standard.

Conditions

Interventions

TypeNameDescription
DEVICENon-contrast MRINon-contrast MRI will be performed on each subject, at both 1.5T and 3.0T. Different MRI sequences (spin-echo and gradient-echo) will be used, with varying acquisition parameters (e.g., echo times, spatial resolution).

Timeline

Start date
2012-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2012-01-25
Last updated
2019-12-06

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT01516853. Inclusion in this directory is not an endorsement.